Patent details

EP1755577 Title: NOVEL USE OF PEPTIDE COMPOUNDS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS

Basic Information

Publication number:
EP1755577
PCT Application Number:
PCT/EP/2005/006169
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057503526
PCT Publication Number:
WO/2005/120476
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL USE OF PEPTIDE COMPOUNDS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS
French Title of Invention:
UTILISATION NOUVELLE DE PEPTIDES POUR LE TRAITEMENT DE LA SCLEROSE AMYTROPHIQUE LATERALE (ALS)
German Title of Invention:
NEUE VERWENDUNG VON PEPTIDVERBINDUNGEN ZUR BEHANDLUNG VON AMYOTHROPHER LATERALSKLEROSE
SPC Number:

Dates

Filing date:
08/06/2005
Grant date:
08/02/2012
EP Publication Date:
08/02/2012
PCT Publication Date:
22/12/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/02/2007
EP B1 Publication Date:
08/02/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/06/2012
Expiration date:
08/06/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/06/2005
 
 

Name:
UCB Pharma GmbH
Address:
Alfred-Nobel-Strasse 10, 40789 Monheim, Germany (DE)

Inventor

Name:
STÖHR Thomas
Address:
Germany (DE)

Priority

1

Priority Number:
578063 P
Priority Date:
09/06/2004
Priority Country:
United States (US)

2

Priority Number:
04013636
Priority Date:
09/06/2004
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 31/165;
Filing date Document type Number of pages